Deciphera Pharmaceuticals, Inc. (DCPH) Financial Statements (2023 and earlier)

Company Profile

Business Address 200 SMITH STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments64,74187,063135,897120,320293,764196,754
Cash and cash equivalents64,74187,063135,897120,320293,764196,754
Receivables22,42920,59513,896   
Inventory, net of allowances, customer advances and progress billings20,56114,1255,716   
Inventory20,56114,1255,716   
Other undisclosed current assets285,227217,231428,522473,0887,2731,428
Total current assets:392,958339,014584,031593,408301,037198,182
Noncurrent Assets
Operating lease, right-of-use asset36,54736,80036,34121,158
Property, plant and equipment6,7078,6109,5836,33313,453838
Long-term investments and receivables14,55041,9509,375   
Long-term investments14,55041,9509,375   
Restricted cash and investments3,2773,1103,1021,5101,069 
Other noncurrent assets      75
Total noncurrent assets:61,08190,47058,40129,00114,522913
TOTAL ASSETS:454,039429,484642,432622,409315,559199,095
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities48,57431,77233,25837,82922,55613,628
Employee-related liabilities11,94517,25512,902  
Accounts payable18,61213,13012,30819,5758,3084,395
Accrued liabilities29,9626,6973,6955,35214,2489,233
Debt    1,747  
Restructuring reserve  20,790    
Due to related parties    187187
Other undisclosed current liabilities37,89544,21136,73420,462  
Total current liabilities:86,46996,77369,99260,03822,74313,815
Noncurrent Liabilities
Long-term debt and lease obligation:  27,99128,76415,904  
Liabilities, other than long-term debt25,879   1,4881,307
Due to related parties    1,1071,294
Other liabilities     38113
Operating lease, liability25,87927,99128,76415,904
Other undisclosed noncurrent liabilities  (27,991)(28,764) 11,347 
Total noncurrent liabilities:25,87927,99128,76415,90412,8351,307
Total liabilities:112,348124,76498,75675,94235,57815,122
Equity
Equity, attributable to parent, including:341,691304,720543,676546,467279,981183,973
Common stock676585576516377 
Additional paid in capital1,575,3611,358,5161,297,5571,033,819575,327379,516
Accumulated other comprehensive income (loss)(983)5111111  
Accumulated deficit(1,233,363)(1,054,432)(754,468)(487,979)(295,723)(195,869)
Other undisclosed equity, attributable to parent      326
Total equity:341,691304,720543,676546,467279,981183,973
TOTAL LIABILITIES AND EQUITY:454,039429,484642,432622,409315,559199,095

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues134,03696,14842,08725,000  
Cost of revenue(8,770)(2,932)(232)   
Cost of goods and services sold(8,770)(2,932)(225)   
Gross profit:125,26693,21641,85525,000  
Operating expenses(307,988)(393,293)(313,045)(225,726)(104,099)(50,935)
Operating loss:(182,722)(300,077)(271,190)(200,726)(104,099)(50,935)
Nonoperating income4,5131134,7018,4704,245651
Other nonoperating income4,5131134,7018,5374,329746
Interest and debt expense    (67)(84)(95)
Loss from continuing operations before income taxes:(178,209)(299,964)(266,489)(192,323)(99,938)(50,379)
Income tax expense (722)     
Other undisclosed loss from continuing operations      
Loss from continuing operations:(178,931)(299,964)(266,489)(192,323)(99,938)(50,379)
Loss before gain (loss) on sale of properties:(299,964)(266,489)(192,323)(99,938)(50,379)
Other undisclosed net income    6784 
Net loss:(178,931)(299,964)(266,489)(192,256)(99,854)(50,379)
Other undisclosed net income attributable to parent      95
Net loss available to common stockholders, diluted:(178,931)(299,964)(266,489)(192,256)(99,854)(50,284)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(178,931)(299,964)(266,489)(192,256)(99,854)(50,379)
Other comprehensive income (loss)(1,034)40    
Comprehensive loss:(179,965)(299,924)(266,489)(192,256)(99,854)(50,379)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (100)111  
Comprehensive loss, net of tax, attributable to parent:(179,965)(299,924)(266,589)(192,145)(99,854)(50,379)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: